Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs & Industries Ltd.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 125 equity shares of Rs. 10 each through the open market on November 18, 2025. The total holding of Ishita Pharmaceuticals moved marginally from 26,160 shares to 26,285 shares. The percentage holding remained unchanged at 0.88% of the total share capital. The total equity share capital of the company stands at Rs. 2,99,03,000 (29,90,300 shares of Rs. 10 each). The acquisition is extremely small and effectively immaterial in percentage terms.
This is a negligible, routine disclosure with no material impact on shareholding pattern or stock price. The related party's stake remains at 0.88%, well below any regulatory threshold, so no significant implications for shareholders.